US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist

1.710
0.0000.00%

Close Dec 4 16:00 ET

1.710
0.0000.00%

Post 19:52 ET

197.01MMarket Cap-19000P/E (TTM)

Coherus BioSciences Stock Forum

Jaguar8

Yesterday 06:27

🟢Watchlist Wednesday, December 4. NFA. Check on my previous watchlist. Those without ✅ means they can have delayed market reaction.

Note: The presence of 30 stock picks reflects the reality that not all stocks respond to their press releases immediately. For instance, today’s market activity saw certain high-performing stocks overshadow promising PRs, suggesting that it may take a day, several days, or even a week for the market to fully digest and react. I encourage you to save the watchlist I p...

71698595

Dec 3 09:18

$Coherus BioSciences (CHRS.US)$ sucks, not looking good anymore

101780576

Dec 3 09:11

$Coherus BioSciences (CHRS.US)$ bullish finally

Ducati999

Dec 3 09:05

Squeeze the shorters!

$Coherus BioSciences (CHRS.US)$ once the shorters got squeeze, easily $4. All in now before its too late.

Macauley Murdock

Dec 3 09:03

Good time to buy

$Coherus BioSciences (CHRS.US)$

Vexn

Dec 3 08:25

This stock flying to the moon tonight!
$Coherus BioSciences (CHRS.US)$

Share Your Profit/Loss

Vexn

Dec 3 08:19

Let's go to the moon!!
$Coherus BioSciences (CHRS.US)$

Share Your Profit/Loss

Jaguar8

Dec 3 06:08

NEWS

$Coherus BioSciences (CHRS.US)$
Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
7 minutes ago, 4:00 AM PST
Via GlobeNewswire
CHRS
Share
- Coherus to focus exclusively on innovative immuno-oncology programs that include LOQTORZI®, an FDA approved, next-generation programmed cell death protein 1 (PD-1) inhibitor -
- Proceeds to fund development of key combination programs with LOQTORZI, including casdozokitug, a first-in-class, cli...